Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae

被引:16
|
作者
Jorgensen, JH
Crawford, SA
McElmeel, ML
Whitney, CG
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[2] Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA
关键词
D O I
10.1128/AAC.48.2.605-607.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of two investigational ketolides, cethromycin (formerly ABT-773) and telithromycin, were determined for a selected group of 312 Streptococcus pneumoniae isolates from a national surveillance program. The MIC of cethromycin at which 50% of the isolates were inhibited was 0.008 mug/ml, and the MIC at which 90% of the isolates were inhibited was 0.06 mug/ml; the corresponding values for telithromycin were less than or equal to0.015 and 0.25 mug/ml, respectively. For six quinupristin-dalfopristin-resistant strains, the cethromycin MICs were 0.25 to 16 mug/ml and the telithromycin MICs were 1 to 4 mug/ml. However, there was only 0.3% resistance to telithromycin.
引用
收藏
页码:605 / 607
页数:3
相关论文
共 50 条
  • [41] Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden
    OlssonLiljequist, B
    Hoffman, BM
    Hedlund, J
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 671 - 675
  • [42] Recent Approaches in Vaccine Development against Streptococcus pneumoniae
    Tarahomjoo, Shirin
    JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY, 2014, 24 (04) : 215 - 227
  • [43] In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany
    Lemmen, S
    Al-Lahham, A
    Lütticken, R
    Reinert, RR
    CHEMOTHERAPY, 2001, 47 (02) : 104 - 109
  • [44] In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children
    Johnson, CN
    Benjamin, WH
    Gray, BM
    Crain, MC
    Edwards, KM
    Waites, KB
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (06) : 531 - 535
  • [45] Comparative activities of β-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates
    Öncü, S
    Punar, M
    Eraksoy, H
    CHEMOTHERAPY, 2004, 50 (02) : 98 - 100
  • [46] Antimicrobial Resistance Among Clinical Isolates of Streptococcus pneumoniae in North America
    Barry, Arthur L.
    AMERICAN JOURNAL OF MEDICINE, 1999, 107 (01): : 28 - 33
  • [47] Clinical levofloxacin-resistant Streptococcus pneumoniae isolates in North Africa
    Ktari, Sonia
    Ben Ayed, Nour El Houda
    Jmal, Ikram
    Mnif, Basma
    Mezghani, Sonda
    Rhimi, Faouzia
    Hammami, Adnene
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 12 : 181 - 182
  • [48] SUSCEPTIBILITY OF RECENT CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE TO 17 ANTIBIOTICS
    WATANAKUNAKORN, C
    GLOTZBECKER, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (01) : 83 - 89
  • [49] Regional trends in β-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004
    Felmingham, David
    Canton, Rafael
    Jenkins, Stephen G.
    JOURNAL OF INFECTION, 2007, 55 (02) : 111 - 118
  • [50] Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
    Pérez-Trallero, E
    García-Rey, C
    Martín-Sánchez, AM
    Aguilar, L
    García-de-Lomas, J
    Ruiz, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2665 - 2667